c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System
GlobeNewswire Inc. | Oct 19, 2026 8:00 AM EDT
Groundbreaking 4-year safety and efficacy results:
Read original article